JP2020531586A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531586A5
JP2020531586A5 JP2020532845A JP2020532845A JP2020531586A5 JP 2020531586 A5 JP2020531586 A5 JP 2020531586A5 JP 2020532845 A JP2020532845 A JP 2020532845A JP 2020532845 A JP2020532845 A JP 2020532845A JP 2020531586 A5 JP2020531586 A5 JP 2020531586A5
Authority
JP
Japan
Prior art keywords
derivative
composition
synthetic lysine
synthetic
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020532845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/046023 external-priority patent/WO2019045989A1/en
Publication of JP2020531586A publication Critical patent/JP2020531586A/ja
Publication of JP2020531586A5 publication Critical patent/JP2020531586A5/ja
Priority to JP2023088440A priority Critical patent/JP2023123440A/ja
Priority to JP2025129144A priority patent/JP2025166032A/ja
Withdrawn legal-status Critical Current

Links

JP2020532845A 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 Withdrawn JP2020531586A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023088440A JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762550656P 2017-08-27 2017-08-27
US62/550,656 2017-08-27
US201862664555P 2018-04-30 2018-04-30
US62/664,555 2018-04-30
PCT/US2018/046023 WO2019045989A1 (en) 2017-08-27 2018-08-09 METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF LYSINE SYNTHETIC ANALOGUES AND MIMETICS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023088440A Division JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2020531586A JP2020531586A (ja) 2020-11-05
JP2020531586A5 true JP2020531586A5 (enExample) 2021-09-16

Family

ID=65525881

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020532845A Withdrawn JP2020531586A (ja) 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2023088440A Withdrawn JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A Pending JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023088440A Withdrawn JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A Pending JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Country Status (11)

Country Link
US (2) US11413279B2 (enExample)
EP (1) EP3672584A4 (enExample)
JP (3) JP2020531586A (enExample)
KR (1) KR102706114B1 (enExample)
CN (1) CN111315374A (enExample)
AU (2) AU2018324427B2 (enExample)
BR (1) BR112020003735A2 (enExample)
CA (1) CA3073685A1 (enExample)
MX (2) MX2020002156A (enExample)
WO (1) WO2019045989A1 (enExample)
ZA (1) ZA202001472B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020376850A1 (en) * 2019-10-29 2022-06-16 Tranexamic Technologies, Llc Synergistic combinations of synthetic lysine analogs, derivatives, mimetics, or prodrugs and pharmaceutical agents for enhanced efficacy
US20230080241A1 (en) * 2020-02-14 2023-03-16 Tranexamic Technologies, Llc Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, and mimetics, and prodrugs
JP2022132181A (ja) * 2021-02-26 2022-09-07 ライオン株式会社 コロナウイルスの細胞侵入抑制剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2203827A1 (en) * 1994-10-28 1996-05-09 Gerard Voerman Novel family of protease inhibitors, and other biologic active substances
WO2000037071A1 (en) * 1998-12-21 2000-06-29 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
US7056947B2 (en) 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
JP4600882B2 (ja) 2002-10-11 2010-12-22 第一三共株式会社 抗インフルエンザウイルス剤
JP2008115168A (ja) * 2006-10-12 2008-05-22 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤
US8980610B2 (en) * 2008-11-20 2015-03-17 Biogen Idec Ma Inc. Arginine inactivation of viruses
JP2010189301A (ja) * 2009-02-17 2010-09-02 Toshihito Eto 新型インフルエンザ感染症に対する医薬組成物およびその利用
US20120082677A1 (en) * 2010-10-01 2012-04-05 Sherif Salah Abdul Aziz Compositions for the treatment of hcv and hbv
US20140271923A1 (en) * 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
CN103405384B (zh) * 2013-09-01 2015-05-13 吴静 氨甲环酸的药物组合物

Similar Documents

Publication Publication Date Title
US9642895B2 (en) Peptides for enhancing transdermal delivery
JP2019513799A5 (enExample)
ITMI20101459A1 (it) Composizione comprendente glutatione reduttasi e glutatione ossidato
JP2013515739A5 (enExample)
RU2012131251A (ru) Композиции и способы для лечения связанных с ангиогенезом заболеваний глаз
MY208749A (en) Biligand drug conjugates and uses thereof
RU2013117209A (ru) Буферные глазные композиции и способы их применения
AR093481A1 (es) Parche de varios dias para la administracion transdermica de rotigotina
JP2020531586A5 (enExample)
BR112016026699A8 (pt) uso de amicacina ou de um sal farmaceuticamente aceitável desta
JP2019528320A5 (enExample)
EP4620525A3 (en) Methods and compositions for treatment of pulmonary hypertension and other lung disorders
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
JP2004507496A5 (enExample)
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
WO2008082507A3 (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
CN102066402B (zh) 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物
RU2010142456A (ru) Синергические комбинации 5'-метилтиоаденозина
KR20250143851A (ko) 신규한 다기능성 올리고펩타이드
JP2025166032A (ja) 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025166032A5 (enExample)
JP2019089834A5 (enExample)
JP2009506978A5 (enExample)
JP2016515137A5 (enExample)
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола